Chronic Obstructive Pulmonary Disease: evidence brief
Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 2,688 matching trials) · https://research.opensourcemed.info/briefs/chronic-obstructive-pulmonary-disease.html
Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.
Medicines with registered trials
Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.
- RV568 (see NCT01475292) 2 trials
- 18 mcg of Spiriva (Reference Product) 1 trial
- Aclidinium bromide 1 trial
- Adjustable bed backrest 1 trial
- Atrovent Respimat (20 mcg) 1 trial
- AZD 2115, Dose 2 1 trial
Non-drug approaches tested
Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.
- Education, coaching and self-management 31 trials · 14 completed · 6 with results
- Pulmonary rehabilitation 43 trials · 17 completed · 3 with results
- Multidisciplinary and other rehabilitation 10 trials · 3 completed · 2 with results
- Sleep and circadian interventions 3 trials · 2 completed · 2 with results
- Breathing and respiratory muscle training 48 trials · 26 completed · 1 with results
- Aerobic and endurance exercise 24 trials · 8 completed · 1 with results
Natural products (RepurpOS Moderate tier)
Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.
- Rhodiola
- Vitamin D3
- N-Acetylcysteine
- Vitamin C
- Creatine
- L-Carnitine
Biomarkers reported
Direction in patients compared with the stated comparison group, as reported in the cited study.
- Alpha-1 Antitrypsin lower · Dasi et al. 2024
- CRP higher · Yanbaeva et al. 2007
- FEV1/FVC ratio lower · Liu et al. 2025
- FEV1 lower · Liu et al. 2025
- Fibrinogen higher · Yanbaeva et al. 2007
Trials recruiting
Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.
- PRA-216 COPD Safety and Biomarker Study NCT07730281
- Phase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination… NCT07896252
- To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With… NCT07684820
- Effects of COPD Standardized Management on COPD Exacerbation NCT04664491
- Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With… NCT07183657
- Digital Therapy in Self-management of COPD Patients NCT06776601
What we don't know yet
Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.
- Oxygen, light, temperature and manual therapies: breathing and lung function 10 trials, no results posted yet
- Cognitive training and education: feasibility, adherence and safety 9 trials, no results posted yet